INOVIO PHARMACEUTICALS, INC.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $31.5M | $26.3M | $44.3M | $36.6M | $24.4M | $39.9M | $65.8M | $21.7M |
| Accounts Receivable | — | — | $450 | $978.6K | $840.3K | $1.3M | $1.2M | $1.9M |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $39.9M | $39.4M | $61.1M | $55.2M | $52.7M | $71.9M | $97.8M | $91.3M |
| Property, Plant & Equipment | $1.9M | $2.2M | $2.5M | $2.7M | $3.1M | $3.3M | $3.7M | $4.1M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $49.4M | $49.8M | $74.3M | $69.4M | $68.2M | $87.3M | $113.2M | $107.1M |
| Liabilities | ||||||||
| Accounts Payable | — | — | — | — | — | — | — | — |
| Total Current Liabilities | $39.9M | $37.9M | $43.7M | $69.8M | $31.7M | $27.3M | $35.3M | $23.5M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $45.0M | $43.7M | $50.2M | $77.1M | $39.7M | $36.0M | $44.7M | $33.5M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.84B | $-1.83B | $-1.82B | $-1.82B | $-1.77B | $-1.75B | $-1.73B | $-1.71B |
| Total Stockholders' Equity | $4.4M | $6.1M | $24.1M | $-7.7M | $28.5M | $51.3M | $68.5M | $73.5M |